| 名称 |
品牌 |
货号 |
规格 |
价格 |
|---|
反苯环丙胺相关化合物B
Tranylcypromine Related Compound B (40 mg) (trans-3-phenylallylamine hydrochloride; cinnamylamine hydrochloride) |
USP |
1672927 |
40mg |
7,680.0010,850.00
|
反苯环丙胺相关化合物A
Tranylcypromine Related Compound A (40 mg) ((+/-)-cis-2-phenylcyclopropanamine hydrochloride; cis-tranylcypromine hydrochloride) |
USP |
1672916 |
40mg |
8,270.0011,690.00
|
硫酸反苯环丙胺
Tranylcypromine Sulfate (125 mg) |
USP |
1672905 |
125mg |
2,430.003,430.00
|
反铂
Transplatin (25 mg) |
USP |
1672803 |
25mg |
8,270.0011,690.00
|
氨甲磺酸相关化合物C
Tranexamic Acid Related Compound C (15 mg) ((RS)-4-(aminomethyl)cyclohex-1-enecarboxylic acid) |
USP |
1672756 |
15mg |
8,610.0012,180.00
|
氨甲环酸
Tranexamic Acid (200 mg) |
USP |
1672745 |
200mg |
2,430.003,430.00
|
群多普利相关化合物E
Trandolapril Related Compound E (25 mg) ((2S,3aR,7aS)-1-[N-[(S)-1-Carboxy-3-phenylpropyl]-L-alanyl]hexahydro-2-indolinecarboxylic acid) |
USP |
1672723 |
25mg |
7,680.0010,850.00
|
群多普利相关化合物D
Trandolapril Related Compound D (25 mg) ((S)-ethyl 2-[(3S, 5aS, 9aR, 10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl]-4-phenylbutanoate) |
USP |
1672712 |
25mg |
7,680.0010,850.00
|
群多普利相关化合物C
Trandolapril Related Compound C (25 mg) ((2S, 3aR, 7aS)-1-[N-[(S)-1-Carboxy-3-cyclohexylpropyl]-L-alanyl]hexahydro-2-indolinecarboxylic acid 1-ethyl ester hydrochloride) |
USP |
1672701 |
25mg |
8,270.0011,690.00
|
群多普利相关化合物A
Trandolapril Related Compound A (25 mg) ((2S,3aR,7aS)-1-[N-[(S)-1-carboxy-3-phenylpropyl]-L-alanyl]hexahydro-2-indolinecarboxylic acid 1-methyl ester) |
USP |
1672698 |
25mg |
7,230.0010,220.00
|
群多普利
Trandolapril (125 mg) |
USP |
1672687 |
125mg |
2,430.003,430.00
|
曲马多相关化合物B
Tramadol Related Compound B (25 mg) (2-(dimethylaminomethyl)-1-cyclohexanone hydrochloride) |
USP |
1672621 |
25mg |
7,680.0010,850.00
|
托拉塞米相关化合物E
Torsemide Related Compound E (20 mg) (4-m-tolyl-2H-pyrido[4,3-e][1,2,4]thiadiazin-3(4H)-one 1,1-dioxide) |
USP |
1672359 |
20mg |
8,270.0011,690.00
|
托拉塞米相关化合物C
Torsemide Related Compound C (30 mg) (N-[(ethylamino)carbonyl]-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide) |
USP |
1672337 |
30mg |
7,680.0010,850.00
|
托拉塞米相关化合物B
Torsemide Related Compound B (50 mg) (N-[(n-butylamino)carbonyl]-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide) |
USP |
1672326 |
50mg |
7,680.0010,850.00
|
托拉塞米相关化合物A
Torsemide Related Compound A (75 mg) (4-[(3-methylphenyl)amino]-3-pyridinesulfonamide) |
USP |
1672315 |
75mg |
7,680.0010,850.00
|
托拉塞米
Torsemide (200 mg) |
USP |
1672304 |
200mg |
2,430.003,430.00
|
托泊替康相关化合物C
Topotecan Related Compound C (25 mg) ((S)-4-Ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione) |
USP |
1672280 |
25mg |
7,230.0010,220.00
|
托泊替康相关化合物A
Topotecan Related Compound A (25 mg) ((S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-8-methoxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione) |
USP |
1672268 |
25mg |
7,920.0011,200.00
|
盐酸托泊替康
Topotecan Hydrochloride (350 mg) |
USP |
1672257 |
350mg |
2,430.003,430.00
|